News
- – Molecular prognostic index may predict survival in early
Molecular prognostic index may predict survival in early-stage NSCLC
A nine-gene molecular prognostic index provided accurate risk stratification and may be used to inform adjuvant therapy for patients with early-stage non–small cell lung cancer, according to the results of a retrospective analysis.“We set out to develop a predictor that could identify which patients with early-stage NSCLC are at highest risk for dying of the disease,” Maximilian
- – EurekAlert!
Nine-gene MPI can provide accurate survival stratification in patients with NSCLC
A nine-gene molecular prognostic index for patients with early-stage non-small cell lung cancer was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease, according to a study published Aug. 18 in the JNCI: Journal of the National Cancer Institute.
- – Time
How Blood Tests Are Changing Medicine
New advances have scientists banking on the idea that the most revealing medical test might be a single drop of your own blood
- – A Genomic Strategy for Residual Disease Monitoring in Non
A Genomic Strategy for Residual Disease Monitoring in Non-Small Cell Lung Cancer
What is the most important thing that stakeholders should know about your research?
- – LongIsland.com
Experts Convene at CSHL to Scrutinize, Assess Low-Dose CT Screening for Lung Cancer
At the first annual Lung Cancer Early Detection and Prevention Workshop held at Cold Spring Harbor Laboratory (CSHL) in late September, nearly two dozen physicians, research scientists and hospital administrators took a close scientific view of rapid advances made in recent years to identify lung ca
- – ABC7 San Francisco
New test spots traces of early lung cancer
The blood test can spot the traces of early lung cancer, long before it might be caught by an imaging test.
- – SFGate
Simple blood test may detect solid cancer tumors
Using tumor samples from patients with non-small-cell lung cancer, the most common form of the disease, the scientists developed a test that accurately identified the earliest stage of the disease in half the people in the study and in all patients with more advanced lung cancer.
- – VOA
Simple Blood Test Could Detect Cancer Early
Early detection screening may be 5 to 10 years off, but the test may also be used for monitoring treatment much sooner
- – Fox News
Simple blood test could detect cancers
A new, highly sensitive blood test may help detect cancer tumors, Medical News Today reported.
- – Cancer blood test edging closer Labmate Online
Cancer blood test edging closer Labmate Online
New research suggests that soon doctors will be able to diagnose and track cancer through a simple blood test. Click to read more...
TV and Radio
- – OncLive
Dr. Diehn on Next Steps With Liquid Biopsies in Lung Cancer
Maximilian Diehn, MD, PhD, an assistant professor in the Department of Radiation Oncology, Stanford Medicine, discusses some of the next steps researchers are taking with liquid biopsies in the field of lung cancer.
- – Cancer Network
ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation Therapy
This peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.
- – Us Weekly
Cancer Test Featured on 'KUWTK' Being Investigated: Details
The Pathway Genomics–created cancer test that was featured on 'Keeping Up With the Kardashians' is being investigated by CBS News for possibly promising patients more than current medical science can deliver — details
- – Blood test giving false sense of security about cancer risk?
Blood test giving false sense of security about cancer risk?
Pathway Genomics claims its liquid biopsy can detect cancer before patient shows symptoms - but expert says that promise is "years away"
- – Vimeo
Spotting Cancer DNA in the Blood
Stanford researchers are able to find and analyze DNA that cancer cells shed into the bloodstream, offering them a way to monitor the progress of anticancer therapy,…
Stanford Medicine News
- – News Center
Stanford scientists among those funded by Stand Up To Cancer
Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.
- – News Center
Stanford scientists among those funded by Stand Up To Cancer
Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.
- – News Center
Stanford scientists among those funded by Stand Up To Cancer
Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.
- – Scope
Predicting lung cancer recurrence by analyzing circulating tumor DNA - Scope
I've mentioned before how circulating tumor DNA, or ctDNA, is likely to be a valuable tool for predicting disease recurrence in patients with lymphoma. Now …
- – News Center
Improved 'liquid biopsy' technique enhances detection of tumor DNA in blood
People with cancer have tumor DNA in their blood. A new way to quiet background “noise” in the blood sample allows researchers to sequence minute quantities of these molecules to improve diagnosis and treatment.
World News
- – mirror
Scientists offer hope to cancer patients forced to endure painful tests
Researchers believe painful biopsies could be replaced with a simple blood tests, ending the painful tests for many
Krebsdiagnose aus dem Blut
Von Ilse Zündorf, Freiburg / Bislang werden Tumore über eine Biopsie analysiert. Doch auch das Blut hält Informationen in Form von freier Tumor-DNA oder einzelnen Tumor-Zellen bereit. Wie weit die Forschung auf dem Gebiet der sogenannten Tumor Liquid Biopsy bereits ist, stellten Experten kürzlich auf einem Symposium in Freiburg vor.
- – PLIVAzdravlje
Krvni test za rak
Američki znanstvenici sa Stanford University su razvili visoko osjetljivi test kojim je moguće otkriti prisutnost raka na temelju uzorka krvi.
- – Αιματολογική εξέταση εντοπίζει τους στερεούς καρκινικους όγκους
Αιματολογική εξέταση εντοπίζει τους στερεούς καρκινικους όγκους
Νέα Yόρκη: Μια νέα αιματολογική εξέταση ανέπτυξαν αμερικανοί ερευνητές που υπόσχεται έγκαιρη διάγνωση των στερεών καρκινικών όγκων, σύμφωνα με στοιχεία που δημοσιεύθηκαν στο επιστημονικό...
- – Real.gr
Τεστ DNA «θα ανιχνεύει γρήγορα τον καρκίνο»
Τεστ DNA «θα ανιχνεύει γρήγορα τον καρκίνο» - Νέα τεχνική από επιστήμονες του Πανεπιστημίου Στάνφορντ8/4/2014 - αρχείο real news, time - Real.gr